ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,652, issued on May 19, was assigned to Keymed Biosciences (Chengdu) Co. LTD (Chengdu, China).
"Bispecific antibody and use thereof" was invented by Bo Chen (Chengdu, China), Gang Xu (Chengdu, China) and Changyu Wang (Chengdu, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a bispecific antibody or an antigen-binding fragment thereof, a nucleic acid encoding the same, a cell comprising the nucleic acid, a composition comprising the bispecific antibody or antigen-binding fragment thereof, the nucleic acid and/or the cell, and related applications of the bispecific antibody or antigen-binding fragment thereof in the treatment of cancer...